Boston Scientific Corp. (BSX)
46.67
-1.50
(-3.11%)
USD |
NYSE |
Aug 27, 16:00
46.86
+0.19
(+0.41%)
Pre-Market: 08:26
Boston Scientific Net Income (Quarterly) : 905.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 905.00M |
| March 31, 2026 | 1.339B |
| December 31, 2025 | 670.00M |
| September 30, 2025 | 755.00M |
| June 30, 2025 | 795.00M |
| March 31, 2025 | 672.00M |
| December 31, 2024 | 562.00M |
| September 30, 2024 | 468.00M |
| June 30, 2024 | 322.00M |
| March 31, 2024 | 493.00M |
| December 31, 2023 | 504.00M |
| September 30, 2023 | 504.00M |
| June 30, 2023 | 270.00M |
| March 31, 2023 | 314.00M |
| December 31, 2022 | 140.00M |
| September 30, 2022 | 188.00M |
| June 30, 2022 | 260.00M |
| March 31, 2022 | 111.00M |
| December 31, 2021 | 94.00M |
| September 30, 2021 | 419.00M |
| June 30, 2021 | 186.00M |
| March 31, 2021 | 341.00M |
| December 31, 2020 | 152.00M |
| September 30, 2020 | -155.00M |
| June 30, 2020 | -147.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.00M |
| December 31, 2019 | 3.996B |
| September 30, 2019 | 126.00M |
| June 30, 2019 | 154.00M |
| March 31, 2019 | 424.00M |
| December 31, 2018 | 386.00M |
| September 30, 2018 | 432.00M |
| June 30, 2018 | 555.00M |
| March 31, 2018 | 298.00M |
| December 31, 2017 | -615.00M |
| September 30, 2017 | 283.00M |
| June 30, 2017 | 146.00M |
| March 31, 2017 | 290.00M |
| December 31, 2016 | 124.00M |
| September 30, 2016 | 228.00M |
| June 30, 2016 | -207.00M |
| March 31, 2016 | 202.00M |
| December 31, 2015 | -142.00M |
| September 30, 2015 | -198.00M |
| June 30, 2015 | 102.00M |
| March 31, 2015 | -1.00M |
| December 31, 2014 | -299.00M |
| September 30, 2014 | 43.00M |
| June 30, 2014 | 4.00M |
| March 31, 2014 | 133.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| Becton, Dickinson & Co. | 451.00M |
| Penumbra, Inc. | 34.81M |
| Insulet Corp. | 95.00M |
| Intuitive Surgical, Inc. | 823.20M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.442B |
| Total Expenses (Quarterly) | 4.535B |
| EPS Diluted (Quarterly) | 0.615 |
| Enterprise Value | 79.74B |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 16.63% |
| Earnings Yield | 5.28% |
| Operating Earnings Yield | 6.58% |
| Normalized Earnings Yield | 5.531 |